Eiko Lifesciences Limited
Eiko Lifesciences Limited is a Public Non-govt company company incorporated in 1977 and based in Maharashtra, India. Eiko Lifesciences Limited operates in Investment activity of ICICI etc. i.e. accepting funds from pubic in different i (NIC 65993) with authorized capital of ₹10.00 Cr and paid-up capital of ₹8.32 Cr. For 2023-24, the company reported revenue of ₹27.93 Cr and profit after tax of ₹75.15 L. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Eiko Lifesciences Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 27 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 20 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Eiko Lifesciences Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 418929000 | Axis Bank Ltd(Bank) | ₹16.08 Cr | 12 Mar 2021 | Open |
| 751098443 | Axis Bank Ltd(Bank) | ₹13.27 Cr | 19 Sep 2023 | Satisfied |
| 982916178 | Kotak Mahindra Bank Ltd(Bank) | ₹6.34 Cr | 19 Sep 2021 | Satisfied |
| 186070530 | HDFC Bank Ltd(Bank) | ₹10.62 Cr | 04 Jul 2022 | Satisfied |
| 104770625 | State Bank of India(Bank) | ₹10.30 Cr | 27 Jan 2022 | Open |
| 245818688 | Kotak Mahindra Bank Ltd(Bank) | ₹16.66 Cr | 12 Mar 2022 | Satisfied |
Charge IDs, lenders & amounts for Eiko Lifesciences Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — | ||||
| 2018-19 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2022-23 | 2021-22 | 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +15.0% | +41.0% | +26.0% | |
| Profit after Tax2023-24 | -5.0% | +6.0% | — | |
| Net Worth2023-24 | +71.0% | +97.0% | +36.0% |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +13.82% | — | +2.56% | +2.36% | — | |||
| 2018-19 | -18.47% | +634.65% | -16.32% | -8.43% | 0.94 | |||
| 2019-20 | -34.80% | +145.03% | -325.53% | -30.03% | 9.84 | |||
| 2020-21 | +5.12% | +15.26% | +4.90% | +3.70% | 0.33 | |||
| 2021-22 | +2.78% | +111.93% | +2.47% | +2.02% | 0.22 | |||
| 2022-23 | +4.20% | -27.90% | +2.61% | +2.48% | 0.06 | |||
| 2023-24 | +2.69% | +52.44% | +1.48% | +1.42% | 0.04 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 2,24,26,679 | 85.80% |
| Institutional Investors | 3 | 8,71,162 | 3.33% |
| Public & Others | 20 | 28,40,248 | 10.87% |
Promoter, institutional & public holding for Eiko Lifesciences Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
169 peersTop 10 in Investment activity of ICICI etc. i.e. accepting funds from pubic in different i
by healthView all ›Events & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.